Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
McKesson
AstraZeneca
Fuji
Accenture
Colorcon
Novartis
McKinsey
Covington

Generated: October 20, 2017

DrugPatentWatch Database Preview

Ranbaxy Company Profile

« Back to Dashboard

What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has fifty-three approved drugs.

There are seventeen tentative approvals on RANBAXY drugs.

Summary for Applicant: Ranbaxy

US Patents:0
Tradenames:38
Ingredients:35
NDAs:53
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy
CARBILEV
carbidopa; levodopa
TABLET, FOR SUSPENSION;ORAL076643-003Jun 10, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
ETODOLAC
etodolac
TABLET;ORAL075226-002Nov 24, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
CEFPROZIL
cefprozil
TABLET;ORAL065198-002Dec 13, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
CEFADROXIL
cefadroxil/cefadroxil hemihydrate
CAPSULE;ORAL065015-001Jun 22, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065043-001Feb 15, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
GLIMEPIRIDE
glimepiride
TABLET;ORAL076875-004Oct 6, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy
EURAX
crotamiton
CREAM;TOPICAL006927-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Ranbaxy
EURAX
crotamiton
LOTION;TOPICAL009112-003Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
DISPERMOX
amoxicillin
TABLET, FOR SUSPENSION;ORAL065080-001Aug 11, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
RANICLOR
cefaclor
TABLET, CHEWABLE;ORAL065092-004Dec 22, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ranbaxy

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ranbaxy
LAC-HYDRIN
ammonium lactate
LOTION;TOPICAL019155-001Apr 24, 1985► Subscribe► Subscribe
Ranbaxy
AVENTYL
nortriptyline hydrochloride
SOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Queensland Health
Dow
AstraZeneca
Julphar
Farmers Insurance
Novartis
Chinese Patent Office
Fuji
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot